Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

635 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact on survival benefits of asymptomatic primary tumor resection after bevacizumab plus FOLFIRI as first-line therapy for patients with metastatic colorectal cancer with synchronous unresectable metastasis.
Chen YC, Chang TK, Su WC, Yeh YS, Chen PJ, Huang PJ, Yang PH, Tsai HL, Wang JY, Huang CW. Chen YC, et al. Among authors: su wc. Int J Colorectal Dis. 2024 Oct 25;39(1):171. doi: 10.1007/s00384-024-04745-1. Int J Colorectal Dis. 2024. PMID: 39453531 Free PMC article.
Predictive Value of ERCC1, ERCC2, and XRCC Expression for Patients with Locally Advanced or Metastatic Gastric Cancer Treated with Neoadjuvant mFOLFOX-4 Chemotherapy.
Yeh YS, Chen YT, Tsai HL, Huang CW, Ma CJ, Su WC, Huang CM, Huang MY, Hu HM, Lu CY, Wang JY. Yeh YS, et al. Among authors: su wc. Pathol Oncol Res. 2020 Apr;26(2):1105-1116. doi: 10.1007/s12253-019-00666-5. Epub 2019 May 10. Pathol Oncol Res. 2020. PMID: 31077069 Free article. Clinical Trial.
Prognostic Value of EGFR Expression for Patients With Stage III Colorectal Cancer Receiving Fluoropyrimidine Metronomic Maintenance Therapy After Radical Resection and Adjuvant Oxaliplatin-Based Chemotherapy.
Huang CW, Ma CJ, Su WC, Chen YT, Tsai HL, Yeh YS, Chang TK, Hsu WH, Yu FJ, Wang JY. Huang CW, et al. Among authors: su wc. Oncol Res. 2021 Sep 7;28(7):701-714. doi: 10.3727/096504020X15986099915822. Epub 2020 Aug 28. Oncol Res. 2021. PMID: 32859280 Free PMC article.
A Pilot Study of Silymarin as Supplementation to Reduce Toxicities in Metastatic Colorectal Cancer Patients Treated With First-Line FOLFIRI Plus Bevacizumab.
Chang TK, Yin TC, Su WC, Tsai HL, Huang CW, Chen YC, Li CC, Chen PJ, Ma CJ, Chuang KH, Cheng TL, Wang JY. Chang TK, et al. Among authors: su wc. Oncol Res. 2021 Sep 7;28(7):801-809. doi: 10.3727/096504021X16218531628569. Epub 2021 May 24. Oncol Res. 2021. PMID: 34030768 Free PMC article. Clinical Trial.
635 results